Michael adducts - Source for biologically potent heterocycles

Chemical and Pharmaceutical Bulletin

Volumn 56, Issue 5, 2008, Pages 647-653

  Padmaja, Adivireddy ^a   Reddy, Gali Sudhakar ^a   Venkata Nagendra Mohan, Annaji ^a   Padmavathi, Venkatapuram ^a  

^a SRI VENKATESWARA UNIVERSITY   (India)

Author keywords

(E) 1,4 diarylbut 2 ene 1,4 dione; Isoxazolidinedione; Michael addition; Pyrazolidinedione; Pyrimidinetrione; Thioxopyrimidinedione

Indexed keywords

1,2 DIMETHYL 5 (1',2' DI(4 METHYLBENZOYL) ETHYL)PYRIMIDINE 2,4,6 TRIONE; 1,3 DIMETHYL 5 (1' (4 METHYLBENZOYL) 2' BENZOYLETHYL)PYRIMIDINE 2,4,6 TRIONE; 1,3 DIMETHYL 5 (1',2' DI(4 CHLOROBENZOYL) ETHYL)PYRIMIDINE 2,4,6 TRIONE; 1,3 DIMETHYL 5 (1',2' DIBENZOYLETHYL)PYRIMIDINE 2,4,6 TRIONE; 4 (1' (4 CHLOROBENZOYL) 2' (4 METHYLBENZOYL) ETHYL)ISOXAZOLIDINE 3,5 DIONE; 4 (1' (4 CHLOROBENZOYL) 2' (4 METHYLBENZOYL) ETHYL)PYRAZOLIDINE 3,5 DIONE; 4 (1' (4 CHLOROBENZOYL) 2' BENZOYLETHYL)ISOXAZOLIDINE 3,5 DIONE; 4 (1' (4 CHLOROBENZOYL) 2' BENZOYLETHYL)PYRAZOLIDINE 3,5 DIONE; 4 (1' (4 METHYLBENZOYL) 2' BENZOYLETHYL)ISOXAZOLIDINE 3,5 DIONE; 4 (1' (4 METHYLBENZOYL) 2' BENZOYLETHYL)PYRAZOLIDINE 3,5 DIONE; 4 (1',2' DI(4 CHLOROBENZOYL) ETHYL)ISOXAZOLIDINE 3,5 DIONE; 4 (1',2' DI(4 CHLOROBENZOYL) ETHYL)PYRAZOLIDINE 3,5 DIONE; 4 (1',2' DI(4 METHYLBENZOYL) ETHYL)ISOXAZOLIDINE 3,5 DIONE; 4 (1',2' DI(4 METHYLBENZOYL) ETHYL)PYRAZOLIDINE 3,5 DIONE; 4 (1',2' DIBENZOYLETHYL)ISOXAZOLIDINE 3,5 DIONE; 4 (1',2' DIBENZOYLETHYL)PYRAZOLIDINE 3,5 DIONE; 5 (1' (4 CHLOROBENZOYL) 2' (4 METHYLBENZOYL) ETHYL)PYRIMIDINE 2,4,6 TRIONE; 5 (1' (4 CHLOROBENZOYL) 2' BENZOYLETHYL)PYRIMIDINE 2,4,6 TRIONE; 5 (1' (4 METHYLBENZOYL) 2' BENZOYLETHYL)PYRIMIDINE 2,4,6 TRIONE; 5 (1',2' DI(4 CHLOROBENZOYL) ETHYL)PYRIMIDINE 2,4,6 TRIONE; 5 (1',2' DI(4 METHYLBENZOYL) ETHYL)PYRIMIDINE 2,4,6 TRIONE; 5 (1',2' DIBENZOYLETHYL)PYRIMIDINE 2,4,6 TRIONE; ANTIINFECTIVE AGENT; DIMETHYL 2 (1' (4 CHLOROBENZOYL) 2' (4 METHYLBENZOYL) ETHYL)MALONATE; DIMETHYL 2 (1' (4 CHLOROBENZOYL) 2' BENZOYLETHYL)MALONATE; DIMETHYL 2 (1' (4 METHYLBENZOYL) 2' BENZOYLETHYL)MALONATE; DIMETHYL 2 (1',2' DI(4 CHLOROBENZOYL) ETHYL)MALONATE; DIMETHYL 2 (1',2' DI(4 METHYLBENZOYL) ETHYL)MALONATE; DIMETHYL 2 (1',2' DIBENZOYLETHYL)MALONATE; UNINDEXED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; MICHAEL ADDITION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE;

ANTI-INFECTIVE AGENTS; BACTERIA; FUNGI; HETEROCYCLIC COMPOUNDS; INDICATORS AND REAGENTS; MAGNETIC RESONANCE SPECTROSCOPY; MICROBIAL SENSITIVITY TESTS; SPECTROPHOTOMETRY, INFRARED;

EID: 43449101571     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.56.647     Document Type: Article

References (23)

1. Goodman L. S., Gilman A., "The Pharmacological Basis of Therapeu-tics," McGraw-Hill, New Delhi, 1991, pp. 358-360.
2. Andres G., "Medical Pharmacology," The CV Mosby Company, Saint Louis, 1976, p. 243.
3. Foye W. O., "Principles of Medicinal Chemistry," Lea and Febiger, London, 1989, p. 159.
4. Meyers F. H., Jawetz E., Goldfien A., "Review of Medical Pharmacology," Lange Medical Publications, Los Altos, California, 1976, p. 222.
5. Wilson and Gisvold's, "Text Book of Organic, Medical and Pharmaceutical Chemistry," J. B. Lippincott Co., Philadelphia, New York, 1991, p. 368.
6. Ed Olin B. R., "Central Nervous System Drugs, Sedatives and Hypnotics, Barbiturates. In Facts and Comparisons Drug Information," Facts and Comparisons, St. Louis, MO, 1993, pp. 1398-1413.
7. Eli Lilly, U.S. Patent 2872448 (1959) [Chem. Abstr., 53 13185D (1959)].
8. Boarland M. P. V., McOmie J. F. W., Timms, R. N., J. Chem. Soc., 4691-4695 (1952).
9. Buchi J., Ammnn J., Lieberherr R., Eichenberger E., Helv. Chim. Acta, 36, 75-78 (1953).
10. Kornet M. J., Thorstenson J. H., Lubawy W. C., J. Pharm. Sci., 63, 1090-1093 (1974).
11. Richon A. B., Maragoudakis M. E., Wasvary J. S., J. Med. Chem., 25, 745-747 (1982).
12. Shinkai H., Onogi S., Tanaka M., Shibata T., Iwao M., Wakitani K., Uchida I., J. Med. Chem., 41, 1927-1933 (1998).
13. Nagai A., Matsushita Y., Ono N., Takechi Y., Jpn. Kokai Tokkyo JP 04173780 (1992) [Chem. Abstr., 117, 212485 (1992)].
14. Dannahardt G., Kiefer W., Kramer G., Maehrlein S., Nowe U., Fiebich B., Eur. J. Med. Chem., 35, 499-510 (2000).
15. Cain C. K., Mallette M. F., Taylor E. C., J. Am. Chem. Soc., 68, 1996-1999 (1946).
16. Arthur C. C., Peter K., Marion B., J. Am. Chem. Soc., 71, 3658-3662 (1949).
17. Gagnon P. E., Boivin J. L., Trembly M., Can. J. Chem., 31, 673-684 (1953).
18. Bhaskar Reddy D., Padmavathi V., Seenaiah B., Padmaja A., Heteroatom Chem., 4, 55-59 (1993).
19. Bhaskar Reddy D., Chandrasekhar Babu N., Padmavathi V., Heteroatom Chem., 12, 131-135 (2001).
20. Padmavathi V., Balaiah A., Venugopal Reddy K., Padmaja A., Bhaskar Reddy D., Indian J. Chem., 41B, 1670-1675 (2002).
21. National Committee for Clinical Laboratory Standards (NCCLS) Approved standard document M-7A, Villanova, PA, 1985.
22. Murray P. R., Baron E. J., Pfaller M. A., Tenover F. C., Yolken R. H., "Manual of Clinical Microbiology," ed. by Wood G. L., Washington J. A., Am. Soc. Microbiol., Washington DC, 1995.
23. William Lown J., Erik Landberg B., Can. J. Chem., 53, 3782-3790 (1975).